icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Direct Acting Antiviral HCV Therapy is Safe and Effective in Patients with Decompensated Cirrhosis: Real World Experience from the HCV-TARGET Cohort
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Authors: Verna EC, Morelli G, Terrault N, Lok AS, Lim J, Di Bisceglie AM, Zeuzem S, Landis C, Lutchman G, Hassan M, Manns M, Vainorius M, Akushevich L, Nelson D, Fried M, Reddy KR for the HCV-TARGET Study Group

AASDL1

AASDL2

AASDL3

AASDL4

AASDL5

AASDL6

AASDL7

AASDL8

AASDL9

AASDL10